Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes

Pil Hyung Lee1, Jung-Min Ahn1, Mineok Chang1

  • 1Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Insights

Percutaneous coronary intervention (PCI) offers comparable outcomes to coronary artery bypass grafting (CABG) for left main coronary artery disease. This study examines long-term trends in unprotected left main disease treatment and outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Left main coronary artery (LMCA) disease is a high-risk subset of ischemic heart disease.
  • Traditionally treated with coronary artery bypass grafting (CABG), recent evidence supports percutaneous coronary intervention (PCI) as a viable alternative.
  • Guidelines now recommend PCI for LMCA disease of low to intermediate anatomic complexity.

Purpose of the Study:

  • To evaluate secular trends in the characteristics, treatment, and long-term clinical outcomes of patients with unprotected LMCA disease.
  • To analyze real-world data on the evolution of LMCA disease management.
  • To provide a comprehensive review of unprotected LMCA disease management and outcomes over time.

Main Methods:

  • Utilized real-world clinical data from the IRIS-MAIN registry.
  • Conducted a broad review of the topic of unprotected LMCA disease.
  • Analyzed secular trends in patient characteristics, treatment strategies, and long-term outcomes.

Main Results:

  • PCI demonstrates comparable clinical outcomes to CABG for LMCA disease.
  • Similar rates of mortality and major adverse cardiac and cerebrovascular events observed between PCI and CABG.
  • CABG is associated with a higher stroke rate, while PCI has a higher rate of repeat revascularization.

Conclusions:

  • PCI is a reasonable alternative to CABG for unprotected LMCA disease, particularly in patients with low to intermediate complexity.
  • Understanding long-term trends is crucial for optimizing treatment strategies in LMCA disease.
  • Real-world data provides valuable insights into the evolving management of this critical condition.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
510
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
873
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
374
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K